G
Galderma Group AG
F:PY30
Galderma Group AG
F:PY30
Price:
35
EUR
-2.78%
Market Closed
Market Cap:
€8.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Galderma Group AG
F:PY30
|
CH |
|
W
|
W W Grainger Inc
XBER:GWW
|
US |
|
I
|
International Business Machines Corp
XETRA:IBM
|
US |
|
Mercedes Benz Group AG
OTC:MBGYY
|
DE |
|
H
|
Honda Motor Co Ltd
XHAM:HDM
|
JP |
|
A
|
Aflac Inc
XHAM:AFL
|
US |
|
D
|
Deluxe Corp
XMUN:DL8
|
US |
|
Burckhardt Compression Holding AG
LSE:0QNN
|
CH |
|
Pitney Bowes Inc
NYSE:PBI
|
US |
|
C
|
Cerence Inc
XETRA:0S6
|
US |
|
Groep Brussel Lambert NV
XBRU:GBLB
|
BE |
|
T
|
TMX Group Ltd
OTC:TMXXF
|
CA |
|
H
|
Huron Consulting Group Inc
XBER:HUR
|
US |
|
N
|
Nomura Real Estate Holdings Inc
XBER:N9U
|
JP |
|
B
|
Best Buy Co Inc
SWB:BUY
|
US |
|
C
|
Cello World Ltd
NSE:CELLO
|
IN |
|
V
|
Vodafone Group PLC
SWB:VODJ
|
UK |
|
E
|
Eldorado Gold Corp
SWB:ELO1
|
CA |
|
E
|
Eldorado Gold Corp
NYSE:EGO
|
CA |
|
M
|
Macquarie Group Ltd
XMUN:4M4
|
AU |
|
S
|
Solaredge Technologies Inc
LSE:0L7S
|
IL |
|
PPC Ltd
OTC:PPCLY
|
ZA |
|
UPM-Kymmene Oyj
OTC:UPMMY
|
FI |
|
T
|
Tyson Foods Inc
SWB:TF7A
|
US |
Income Statement
Earnings Waterfall
Galderma Group AG
Galderma Group AG
Income Statement
Galderma Group AG
Galderma Group AG
Currency:
| Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|
| Revenue | ||||
| Interest Expense |
352
|
0
|
0
|
|
| Revenue |
4 440
N/A
|
4 690
+6%
|
5 241
+12%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(1 355)
|
(1 444)
|
(1 627)
|
|
| Gross Profit |
3 085
N/A
|
3 246
+5%
|
3 614
+11%
|
|
| Operating Income | ||||
| Operating Expenses |
(2 410)
|
(2 491)
|
(2 727)
|
|
| Selling, General & Administrative |
(1 920)
|
(2 022)
|
(2 196)
|
|
| R&D |
(260)
|
(229)
|
(245)
|
|
| Depreciation & Amortization |
0
|
0
|
(37)
|
|
| Other Operating Expenses |
(230)
|
(240)
|
(249)
|
|
| Operating Income |
675
N/A
|
755
+12%
|
887
+17%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
(345)
|
(217)
|
(191)
|
|
| Non-Recurring Items |
(26)
|
(42)
|
(39)
|
|
| Total Other Income |
6
|
(11)
|
(19)
|
|
| Pre-Tax Income |
310
N/A
|
485
+56%
|
638
+32%
|
|
| Net Income | ||||
| Tax Provision |
(79)
|
(107)
|
(26)
|
|
| Income from Continuing Operations |
231
|
378
|
612
|
|
| Net Income |
231
N/A
|
378
+64%
|
613
+62%
|
|
| EPS (Diluted) |
0.97
N/A
|
1.59
+64%
|
2.59
+63%
|
|
Switch to:
Switch to:
See Also
Other Galderma Group AG listings:
Discover More
